Reduction in caffeine withdrawal after open-label decaffeinated coffee.
Llewellyn MillsJessica C LeeRobert A BoakesBen ColagiuriPublished in: Journal of psychopharmacology (Oxford, England) (2023)
It appears as if open-label placebo caffeine (i.e. decaf) can reduce caffeine withdrawal symptoms, even when people do not hold a conscious expectancy it will do so. There may be ways to integrate open-label placebo procedures into clinical interventions for drug dependence without violating informed consent.